Concepedia

Aaron Kunzer

AK

Statistics

Publications

15

Citations

4.7K

H-Index

15

Active since

2002

Affiliations

Abbott Fund(Current)

Abbott (United States)

AbbVie (United States)

Aaron Kunzer is an author at Abbott Fund specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2002–2024

15

Publications

15

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations

, , +14

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Milan Bruncko, Thorsten Oost, Barbara Belli et al. · Journal of Medicinal Chemistry · 2007 · 295 citations · Full text

, , +14

Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins

Cheol‐Min Park, Milan Bruncko, Jessica Adickes et al. · Journal of Medicinal Chemistry · 2008 · 293 citations · Full text

, , +16

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> Inhibitor

Le Wang, George Doherty, Andrew S. Judd et al. · ACS Medicinal Chemistry Letters · 2020 · 136 citations · Full text

, , +16

Discovery and Structure−Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo

Michael Wendt, Shen Wang, Aaron Kunzer et al. · Journal of Medicinal Chemistry · 2006 · 131 citations · Full text

, , +17

1–5 of 15